Literature DB >> 20185298

Alpha-fetoprotein-producing non-germ cell tumours of the female genital tract.

M El-Bahrawy1.   

Abstract

Elevated levels of alpha-fetoprotein (AFP), a foetal serum protein, occur mainly on the development of hepatocellular carcinoma (HCC) or germ cell tumours, including yolk sac tumour (YST) and embryonal carcinoma of the ovary. Rarely, other tumours of the female genital tract produce AFP. This article reviews the AFP-producing non-germ cell tumours reported in different parts of the female genital tract to date. These include different types of carcinomas and carcinosarcomas of the uterus, ovary and cervix and sex cord stromal tumours of the ovary. It is important for both pathologists and oncologists to be aware of such cases and the clinicopathological distinction from germ cell tumours, as the diagnosis would affect the management plan for the patient. The reviewed cases suggest that regardless of the patient's age when no lesion is detected in the liver and stomach of a woman whose serum AFP level is abnormally high, the female reproductive system should be examined as a possible site of AFP-producing tumour. Biochemical, physiological and pathological features of AFP are briefly presented. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185298     DOI: 10.1016/j.ejca.2010.01.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  α-fetoprotein produced by endometrioid adenocarcinoma of uterus.

Authors:  Ali Akhavan; Mojgan Karimi Zarchi; Mahmood Akhavan Tafti; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-06-25

2.  The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.

Authors:  Yakup Bozkaya; Mutlu Doğan; Ozan Yazıcı; Gökmen Umut Erdem; Nebi Serkan Demirci; Nurullah Zengin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

Review 3.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

Review 4.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

5.  α-Fetoprotein-Producing Non-Germ Cell Tumors of the Urological System.

Authors:  Mona El-Bahrawy
Journal:  Rev Urol       Date:  2011

6.  Immunohistochemical and molecular analysis of an α-fetoprotein-producing cervical adenocarcinoma with clear cell morphology.

Authors:  Shu Kuriyama; Mitsutake Yano; Takahiro Kusaba; Sumika Zaitsu; Haruto Nishida; Masanori Yasuda; Kaei Nasu
Journal:  Med Mol Morphol       Date:  2022-10-02       Impact factor: 2.070

Review 7.  Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists.

Authors:  Mariana Horta; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Jul-Aug       Impact factor: 2.630

8.  Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer.

Authors:  H J Lin; Y H Hsieh; W L Fang; K H Huang; A F Y Li
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

9.  Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.

Authors:  Ya-Kun Wang; Lin Shen; Xi Jiao; Xiao-Tian Zhang
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

10.  Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis.

Authors:  Yakun Wang; Lin Shen; Ming Lu; Zhi Ji; Xiaotian Zhang
Journal:  Gastroenterol Res Pract       Date:  2017-12-24       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.